Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
26.49Price to Operating Cash Flow
VS
Market
Sector
Industry
History
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information
Ticker
CRMDCompany Name
CORMEDIX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCORMEDIX INC - Price to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRMD - P/OCF Historical data
| Date | Market Capitalization | Net Cash Flow - Operations | Price to Operating Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 806.96M | $ 30.46M | 26.49 |
| 3/31/2025 | $ 756.92M | $ -13.57M | 0 |
| 12/31/2024 | $ 478.43M | $ -50.61M | 0 |
| 9/30/2024 | $ 609.81M | $ -55.75M | 0 |
| 6/30/2024 | $ 274.83M | $ -50.79M | 0 |
| 3/31/2024 | $ 297.33M | $ -45.33M | 0 |
| 12/31/2023 | $ 188.04M | $ -38.41M | 0 |
| 9/30/2023 | $ 171.56M | $ -33.82M | 0 |
| 6/30/2023 | $ 242.24M | $ -31.12M | 0 |
| 3/31/2023 | $ 233.7M | $ -28.01M | 0 |
Key Performance Insights, Last 5 Years
- CORMEDIX INC's latest trailing twelve months (TTM) P/OCF stands at 0.
- Over the past 5 years, CORMEDIX INC's average P/OCF has been 26.49.
- The median P/OCF for CORMEDIX INC during this period was 26.49
- CORMEDIX INC reached its highest P/OCF over the past 5 years at 26.49.
- The lowest P/OCF recorded by CORMEDIX INC in the same timeframe 26.49
CORMEDIX INC's P/OCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/OCF Benchmarks
Similar metrics to P/OCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Price to Operating Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].Market Cap / CF - Operations
(=) P/OCF P/OCF for CORMEDIX INC is calculated as follows: Market Cap [ $ 172.87M ] / CF - Operations [ $ -19.92M ]
(=) P/OCF [ 0 ] CRMD - Price to Operating Cash Flow, Last 5 years
26.49
Minimum
Jun 30, 2025
26.49
Maximum
Jun 30, 2025
26.49
Average
26.49
Median
P/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.1 with a standard deviation of 8.81.
The following table provides additional summary stats:
P/OCF in the Market:
| filtered constituents | 2.56K |
|---|---|
| min | 0.08 |
| max | 42.03 |
| average | 13.1 |
| median | 10.77 |
| std | 8.81 |